The Economics of General Thromboembolic Prophylaxis

Overview

Journal World J Surg

Publisher Wiley

Specialty General Surgery

Date 1988 Jun 1

PMID 3400247

Citations 9

Authors

D Bergqvist

S Jendteg

B Lindgren

T Matzsch

U Persson

Affiliations

Soon will be listed here.

Citing Articles

Current use of thromboembolism prophylaxis for laparoscopic cholecystectomy patients in Sweden.

Lindberg F, Bjorck M, Rasmussen I, Bergqvist D Surg Endosc. 2004; 19(3):386-8.

PMID: 15573240 DOI: 10.1007/s00464-004-9095-3.

Cost effectiveness of desirudin compared with a low molecular weight heparin in the prevention of deep vein thrombosis after total hip replacement surgery.

Levin L, Bergqvist D Pharmacoeconomics. 2001; 19(5 Pt 2):589-97.

PMID: 11465303 DOI: 10.2165/00019053-200119050-00012.

Cost-effectiveness of low-molecular-weight heparin in the treatment of proximal deep vein thrombosis.

Estrada C, Mansfield C, Heudebert G J Gen Intern Med. 2000; 15(2):108-15.

PMID: 10672114 PMC: 1495337. DOI: 10.1046/j.1525-1497.2000.03349.x.

Cost effectiveness of the prevention and treatment of deep vein thrombosis and pulmonary embolism.

Anderson D, OBrien B Pharmacoeconomics. 1997; 12(1):17-29.

PMID: 10169385 DOI: 10.2165/00019053-199712010-00003.

Constraints on antidepressant prescribing and principles of cost-effective antidepressant use. Part 2: Cost-effectiveness analyses.

Henry J, Rivas C Pharmacoeconomics. 1997; 11(6):515-37.

PMID: 10168093 DOI: 10.2165/00019053-199711060-00002.

References

Basu D, Gallus A, Hirsh J, Cade J . A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time. N Engl J Med. 1972; 287(7):324-7. DOI: 10.1056/NEJM197208172870703. View

Pitney W, Pettit J, Armstrong L . Control of heparin therapy. Br Med J. 1970; 4(5728):139-41. PMC: 1819897. DOI: 10.1136/bmj.4.5728.139. View

Holm H, Abildgaard U, Kalvenes S . Heparin assays and bleeding complications in treatment of deep venous thrombosis with particular reference to retroperitoneal bleeding. Thromb Haemost. 1985; 53(2):278-81. View

Norman C, Provan J . Control and complications of intermittent heparin therapy. Surg Gynecol Obstet. 1977; 145(3):338-42. View

Glazier R, Crowell E . Randomized prospective trial of continuous vs intermittent heparin therapy. JAMA. 1976; 236(12):1365-7. View

Mant M, OBrien B, Thong K, Hammond G, Birtwhistle R, GRACE M . Haemorrhagic complications of heparin therapy. Lancet. 1977; 1(8022):1133-5. DOI: 10.1016/s0140-6736(77)92388-1. View

KERNOHAN R, Todd C . Heparin therapy in thromboembolic disease. Lancet. 1966; 1(7438):621-3. DOI: 10.1016/s0140-6736(66)90822-1. View

Rooke T, OSMUNDSON P . Heparin and the in-hospital management of deep venous thrombosis: cost considerations. Mayo Clin Proc. 1986; 61(3):198-204. DOI: 10.1016/s0025-6196(12)61849-7. View

Lindhagen A, Bergqvist D, Hallbook T . Deep venous insufficiency after postoperative thrombosis diagnosed with 125I-labelled fibrinogen uptake test. Br J Surg. 1984; 71(7):511-5. DOI: 10.1002/bjs.1800710713. View

10.

Salzman E, Deykin D, SHAPIRO R, Rosenberg R . Management of heparin therapy: Controlled prospective trial. N Engl J Med. 1975; 292(20):1046-50. DOI: 10.1056/NEJM197505152922002. View

11.

Jick H, Slone D, Borda I, Shapiro S . Efficacy and toxicity of heparin in relation to age and sex. N Engl J Med. 1968; 279(6):284-6. DOI: 10.1056/NEJM196808082790603. View

12.

Vieweg W, Piscatelli R, Houser J, Proulx R . Complications of intravenous administration of heparin in elderly women. JAMA. 1970; 213(8):1303-6. View

13.

Svensson J, Blomback M, Kockum C . [Ambulatory treatment of 1,741 patients. High frequency of hemorrhagic complications in anticoagulant therapy]. Lakartidningen. 1985; 82(14):1240-4. View

14.

Wilson J, Lampman J . Heparin therapy: a randomized prospective study. Am Heart J. 1979; 97(2):155-8. DOI: 10.1016/0002-8703(79)90349-1. View